POPULARITY
In this episode, Dr. Stuart Slavin is joined by Julie Beckerdite, director of education for the Departments of Pathology and Psychiatry, and Carrie Racsumberger, fellowship program manager in the Department of Pathology - both at Mass General Brigham. Together, they share insights from their work on the ACGME Coordinator Advisory Group in a practical conversation on the relationships that shape the program coordinator role in graduate medical education (GME). Drawing on their experience, Beckerdite and Racsumberger discuss how interactions with residents, fellows, faculty members, and program leaders can be both a major source of satisfaction and a source of ongoing challenge. They share strategies for setting expectations early, communicating effectively, and addressing common issues like delayed responses, professionalism concerns, and recurring administrative demands. They also emphasize the importance of establishing clear boundaries with the support of leadership while maintaining a respectful, collaborative approach that promotes accountability and teamwork. The conversation highlights the meaningful connections coordinators build with residents/fellows, and the important role they play in supporting professional development and fostering psychological safety within programs. Throughout the discussion, Beckerdite and Racsumberger emphasize perspective-taking, consistency, and the value of strong relationships in navigating difficult situations. Listeners will gain practical insights into how intentional communication and clear role definition can strengthen team culture and enhance the coordinator experience in GME. Podcast Chapters (00:00) – Intro and Guest Introduction (00:45) – Focus on Coordinator Well-Being and Relationships (02:10) – Managing Task Completion and Setting Expectations (04:41) – Using Leadership Support and Accountability (06:45) – Coordinator Role in Professionalism and Recruitment (09:20) – Setting Boundaries and Defining the Coordinator Role (11:45) – Finding Satisfaction in Resident Relationships (13:25) – Managing Difficult Interactions and Perspective (15:52) – Growth, Meaning, and Supporting Trainees (16:26) – Psychological Safety and Connection (17:23) – Coordinators as Leaders (18:20) – Closing and Resources
In this episode, we will focus on the latest in the research on ALS. ALS remains a devastating disease, but the field is now at an inflection point with a growing pipeline of precision therapies, trial-ready sites, and a new generation of clinician scientists - yet barriers persist. There is disease heterogeneity, limited trial access for patients, and rising development costs. For an update on ALS clinical trials and the Healey ALS MyMatch program, a centralized platform that matches participants to trials, we spoke with Dr. Suma Babu. Dr. Suma Babu is an associate professor of neurology at Harvard Medical School and co-director of the Neurological Clinical Research Institute at Mass General Brigham. She was interviewed by Dr. Ryan Jacobson, an associate professor of neurology at Rush University. Disclosure: This episode does not award CME.
A simple test with 12 questions may help predict your risk of dementia, stroke, or depression says Dr Jonathan Rosand. He's the founder and director of the Brain Care Labs at Mass General Brigham and Harvard, and professor of Neurology at Harvard Medical School. He's developed the Brain Care Score that measures factors such as sleep, exercise, stress, blood pressure, and social connection. The goal is to show how small changes to everyday habits may help protect brain health and reduce the risk of disease. Now, through the Global Brain Care Consortium, that work is expanding worldwide, inviting people to track their brain health and contribute to long-term research. To learn your Brain Care Score go HERE or visit the Global Brain Care Coalition website to learn more about its work and how to get involved HERE
In this episode, Amy Lee, President and COO of Mass General Brigham's Nantucket Cottage Hospital,discusses leading a rural island hospital through seasonal population surges, workforce housing challenges, and care coordination for complex patients.
In this episode, Amy Lee, President and COO of Mass General Brigham's Nantucket Cottage Hospital,discusses leading a rural island hospital through seasonal population surges, workforce housing challenges, and care coordination for complex patients.
8:05PM: Boston Globe Reporter Emily Sweeney (a regular guest on NightSide) on her newfound “fame” after taking her reporting to social media and going viral for her Boston accent. Guest: Emily Sweeney – Boston Globe Reporter 8:15PM: With Memorial Day weekend marking the unofficial start of summer, these are some timely, practical safety tips for parents and grandparents to help keep kids safe all season long. Guest: Dr. Alexy Arauz Boudreau – Primary Care Physician with Mass General Brigham 8:30PM: A New Survey by The Harris Poll Highlights the Rising Issue of Misinformation in Science and Health…Survey of over 2,000 US adults reveals a profound “Misinformation Paradox” around science that cuts at the heart of American life… Guest: Matthias Berninger - Bayer’s Head of Public Affairs, Sustainability and Safety 8:45PM: How the U.S. Senate is taking legislative steps to prevent government shutdowns from happening ever again… Guest: Kurt Couchman - Senior Fiscal Policy Fellow at Americans for ProsperitySee omnystudio.com/listener for privacy information.
Heart disease is the leading cause of death in women, yet awareness is still surprisingly low. In this episode of The Positive Pause®, host Claire Gill sits down with two of NMF's Medical Advisory Committee (MAC) members, Dr. Emily Lau, a cardiologist specializing in women's cardiovascular health, and Michelle Routhenstein, a preventive cardiology dietitian, to unpack why midlife is a critical window for prevention and what women can do to take control of their heart health.They explore how menopause changes cardiovascular risk, why heart disease often goes unnoticed, and how small, sustainable lifestyle changes can have a major impact.Emily Lau, MD, MPH a women's cardiovascular health specialist and investigator at Mass General Brigham. Dr. Lau co-directs the Women's Heart Health Program. Dr. Lau's laboratory focuses on understanding how biologic sex differences and female-specific cardiovascular risk factors contribute to the pathogenesis of cardiovascular disease uniquely in women. Michelle Routhenstein, MS, RD, CDCES, CDN, is the owner and president of Entirely Nourished LLC, a specialized private practice in nutrition counseling and consulting focused on the prevention and management of heart disease. Employing a science-based, holistic approach, she is dedicated to enhancing women's heart health by addressing cardiometabolic risk factors and mitigating the likelihood of cardiovascular issues as individuals age.Key Concepts CoveredMidlife is a turning point for heart healthCardiovascular risk accelerates during and after menopause, making this stage of life a critical opportunity for prevention.Heart disease is often silent and under-recognizedMany women don't realize there's an issue because symptoms aren't obvious. At the same time, awareness has actually declined in recent years, which makes education even more important.Health goes beyond weight and appearanceYou can look healthy and still have underlying cardiovascular risk. That's why personalized testing and understanding your numbers matters.Sustainable habits matter more than extreme changesInstead of restrictive diets or drastic routines, small consistent improvements in nutrition, movement, sleep, and stress management lead to better long-term outcomes.Prevention is the real opportunityMidlife isn't just a time of change; it's a chance to take control. With the right approach, most cardiovascular risk factors can be improved or prevented.This conversation makes one thing clear: heart health isn't something women can afford to ignore, especially at midlife. The good news is that most risk factors are preventable and manageable with the right information and consistent action. By focusing on sustainable habits and understanding your personal risk, you can take control of your cardiovascular health and build a stronger future.Connect with Dr. Lau:Website: Mass General Brigham Women's Heart HealthLinkedIn: https://www.linkedin.com/in/emily-lau-11601152/ Instagram: https://www.instagram.com/massgeneral Connect with Michelle:Website: https://www.entirelynourished.comLinkedIn: https://linkedin.com/in/michellerouthenstein/Instagram: https://www.instagram.com/heart.Health.Nutritionist/
Et si l'un des premiers signes de la maladie d'Alzheimer ne se cachait pas dans la mémoire… mais dans le nez ? Cela peut sembler surprenant, pourtant une étude menée par une équipe du Mass General Brigham et publiée dans la revue Neurosciences Scientific Reports suggère qu'un simple test de l'odorat pourrait révolutionner le dépistage précoce d'Alzheimer. Depuis plusieurs années, les chercheurs savent que la perte de l'odorat est liée à certaines maladies neurodégénératives. Ce n'est pas un hasard : les régions cérébrales qui traitent les odeurs, comme le bulbe olfactif et le cortex entorhinal, figurent parmi les premières zones touchées par Alzheimer. Bien avant les gros troubles de mémoire, le cerveau commence donc parfois à perdre sa capacité à reconnaître les odeurs. Les chercheurs américains ont voulu exploiter cette piste avec un test très simple, baptisé “AROMHA Brain Health Test”. Le principe est étonnamment basique : des cartes à gratter et à sentir. Les participants doivent identifier différentes odeurs, les distinguer les unes des autres et parfois les mémoriser. Tout cela peut même être réalisé à domicile, sans médecin ni machine sophistiquée. L'étude a porté sur plusieurs groupes : des adultes en bonne santé, des personnes se plaignant de petits problèmes de mémoire, et d'autres souffrant déjà de troubles cognitifs légers — ce qu'on appelle le “mild cognitive impairment”, souvent considéré comme une étape précoce vers Alzheimer. Résultat : les personnes présentant des troubles cognitifs obtenaient de moins bons scores dans les tests olfactifs, notamment pour reconnaître et différencier les odeurs. Ce qui rend cette découverte particulièrement importante, c'est son potentiel pratique. Aujourd'hui, détecter Alzheimer précocement est compliqué. Les examens les plus fiables, comme certains scanners cérébraux ou analyses du liquide céphalo-rachidien, sont coûteux, invasifs ou difficiles d'accès. À l'inverse, un test olfactif pourrait être rapide, peu cher et utilisable à grande échelle. Attention toutefois : ce test ne permet pas, à lui seul, de diagnostiquer Alzheimer. Perdre l'odorat peut avoir de nombreuses causes, comme le vieillissement, certaines infections ou d'autres maladies neurologiques. Mais ce type d'outil pourrait devenir un signal d'alerte très précoce, permettant d'identifier les personnes à risque avant même l'apparition des grands symptômes. Et c'est là tout l'enjeu. Car dans Alzheimer, le cerveau peut commencer à se dégrader dix à vingt ans avant les premiers oublis visibles. Détecter la maladie plus tôt pourrait permettre d'agir plus rapidement, de ralentir son évolution et, un jour peut-être, de prévenir l'apparition des symptômes.Autrement dit, dans le futur, diagnostiquer Alzheimer pourrait peut-être commencer… par un simple “grattez et sentez”. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.
Dr. Paul D. Biddinger, Chief Preparedness and Continuity Officer at Mass General Brigham and one of the nation's foremost authorities on disaster medicine, joins WarDocs to deliver an unflinching assessment of the United States' readiness to manage mass battlefield casualties in a large-scale combat operations (LSCO) scenario. Drawing on nearly 30 years as a practicing emergency physician, his leadership of the National Special Pathogen System, and his co-PI role on a Henry M. Jackson Foundation-funded LSCO readiness project, Dr. Biddinger illuminates the critical gaps — and the urgent solutions — that will determine whether Team America can meet the medical demands of tomorrow's wars. The conversation opens with Dr. Biddinger's distinctive academic trajectory: international relations and public policy at Princeton before medical school, a combination that instilled a deep appreciation for the policy infrastructure that either enables or obstructs effective healthcare coalitions. That framework shapes his entire approach to LSCO readiness, where the challenge is never a single hospital or a single physician — it is always the system. Dr. Biddinger identifies data silos as the foundational failure threatening LSCO response. The civilian healthcare system is already operating at or above capacity in most American cities, and the Federal Coordinating Centers within the National Disaster Medical System lack the real-time clinical expertise needed to make sophisticated patient regulation decisions. He argues for urgent integration of civilian-side patient transfer intelligence with military command structures — ensuring that warfighters returning home at scale are routed to the right bed, with the right subspecialty capability, rather than flooding Level I trauma centers and displacing civilian critical care. The Ukraine conflict provides sobering real-world data: drone-driven injury patterns unfamiliar to most civilian trauma surgeons, extended evacuation timelines that demand adaptive point-of-injury care, and an overwhelmed rehabilitation pipeline that the U.S. system is wholly unprepared to replicate. Dr. Biddinger draws direct parallels to the Boston Marathon bombing response, where tactical combat casualty care principles — rapid hemorrhage control, aggressive patient distribution, and relentless questioning of old-school disaster assumptions — saved lives that a conventional mass casualty protocol would have lost. The episode closes with two pieces of career advice for young military medicine professionals: question every assumption respectfully and within proper command structures, and be a passionate, data-driven advocate for systems change. The Joint Trauma System's continuous learn-and-adapt model is held up as the gold standard. Dr. Biddinger's message is clear — the next large-scale conflict will be won or lost in part by how effectively military and civilian medicine learn to speak the same operational language before the shooting starts. Chapters (00:00-02:30) From International Relations to Emergency Medicine: Building Systems-Level Thinking (02:30-07:37) LSCO Readiness Gaps: Data, Capacity, and the Civilian Healthcare System (07:37-13:58) Federal Coordination, Ukraine Lessons, and the Rehabilitation Crisis (13:58-19:24) AI, Heat Injury Prevention, and Patient Surge Load Balancing (19:24-26:30) National Special Pathogen System and All-Hazard Response Leadership (26:30-38:40) Boston Marathon Bombing Lessons, Innovation Culture, and the Future of Military Medicine Chapter Summaries (00:00-02:30) From International Relations to Emergency Medicine: Building Systems-Level Thinking Dr. Biddinger traces his unconventional path from Princeton's international relations program to nearly 30 years as a practicing emergency physician. He explains how policy training shaped his conviction that no individual doctor or hospital succeeds in isolation — effective disaster response is fundamentally a systems problem, and the policy infrastructure surrounding those systems determines everything. (02:30-07:37) LSCO Readiness Gaps: Data, Capacity, and the Civilian Healthcare System Drawing on his Henry M. Jackson Foundation LSCO project, Dr. Biddinger identifies the civilian healthcare system's chronic overcapacity as the primary threat to absorbing mass battlefield casualties. He quantifies the challenge — a hundred thousand extra patients over a hundred days — and explains why real-time data integration across hospital systems, state lines, and trauma center capabilities is the non-negotiable foundation of any viable patient distribution plan. He specifically flags EMS workforce shortages as an underappreciated rate-limiting factor. (07:37-13:58) Federal Coordination, Ukraine Lessons, and the Rehabilitation Crisis Dr. Biddinger critiques the current Federal Coordinating Center structure as insufficiently connected to civilian-side clinical expertise, and calls for direct integration of military command data with civilian patient tracking systems. He applies lessons from the Ukraine conflict — drone injury patterns, extended evacuation timelines, and rehabilitation system collapse — to underscore how fundamentally different LSCO will be from the counter-insurgency environments most current military medical leaders trained in. (13:58-19:24) AI, Heat Injury Prevention, and Patient Surge Load Balancing Dr. Biddinger describes his IBM Sustainability Accelerator collaboration developing AI-driven early warning systems for extreme heat events, and explains how that same data integration logic applies to battlefield thermal stress monitoring and real-time casualty tracking via the Joint Trauma System. He then walks through the COVID-era Boston hospital load-balancing system he helped build — competitive hospitals sharing real-time bed and ICU data and making collaborative surge decisions multiple times daily — and explores how that model translates to theater patient regulation. (19:24-26:30) National Special Pathogen System and All-Hazard Response Leadership Dr. Biddinger explains the tiered architecture of the National Special Pathogen System — the infectious disease analog to the trauma center hierarchy — and its identify-isolate-inform framework, developed from the 2014 West African Ebola outbreak. He applies the framework directly to military medicine, emphasizing the importance of maintaining high clinical suspicion, knowing real-time global outbreak data, and preserving robust reach-back capability to specialty expertise. He closes with field lessons from Hurricane Katrina, Nepal earthquake response, and the Haiti earthquake on integrating civilian and military assets under ESF-8 and WHO cluster structures. (26:30-38:40) Boston Marathon Bombing Lessons, Innovation Culture, and the Future of Military Medicine Dr. Biddinger credits tactical combat casualty care principles from Gulf War I and II for the lives saved at the Boston Marathon bombing, specifically the pivot away from staged triage toward rapid hemorrhage control and immediate hospital distribution. He documents how Boston EMS cleared more than 60 critical casualties in 18 minutes. The episode closes with career guidance for young military medicine professionals: question every assumption within appropriate command structures, remain data-driven, and be a fierce advocate for systems that better serve the injured warfighter. Biography Dr. Paul Biddinger is the Chief Preparedness and Continuity Officer at Mass General Brigham (MGB) and the Chief of the Division of Emergency Preparedness in the Department of Emergency Medicine at MGB. He holds the Ann L. Prestipino MPH Endowed Chair in Emergency Preparedness and is also the Director of the Center for Disaster Medicine at Massachusetts General Hospital (MGH). Dr. Biddinger additionally serves as the Director of the Emergency Preparedness Research, Evaluation and Practice (EPREP) Program at the Harvard T. H. Chan School of Public Health and holds appointments at Harvard Medical School and at the Chan School. Dr. Biddinger serves as a medical officer for the MA-1 Disaster Medical Assistance Team (DMAT) in the National Disaster Medical System (NDMS) in the US Department of Health and Human Services (HHS). Dr. Biddinger is an active researcher in the field of emergency preparedness and has lectured nationally and internationally on topics of preparedness and disaster medicine. He has authored numerous articles and book chapters on multiple topics related to disaster medicine and emergency medical operations and has responded to numerous prior disaster events, including Hurricane Katrina, Superstorm Sandy, the Boston Marathon bombings, the Nepal earthquakes, and many others. He completed his undergraduate study in international relations at Princeton University, attended medical school at Vanderbilt University, and completed residency training in emergency medicine at Harvard. Episode Keywords military medicine, large-scale combat operations, LSCO, disaster medicine, emergency medicine, Paul Biddinger, Mass General Brigham, patient surge, civilian military integration, Henry M. Jackson Foundation, National Disaster Medical System, NDMS, Federal Coordinating Centers, trauma system, combat casualty care, Boston Marathon bombing, Ukraine war lessons, drone injuries, mass casualty, hemorrhage control, tactical combat casualty care, TCCC, National Special Pathogen System, Ebola preparedness, AI in medicine, heat injury prevention, hospital capacity, patient distribution, military healthcare, WarDocs podcast Hashtags #MilitaryMedicine, #WarDocs, #LargeScaleCombatOperations, #DisasterMedicine, #CombatCasualtyCaree, #EmergencyMedicine, #MilitaryReadiness, #TCCC Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to honor the legacy, preserve the oral history, and showcase career opportunities, unique expeditionary experiences, and achievements of Military Medicine. We foster patriotism and pride in Who we are, What we do, and, most importantly, How we serve Our Patients, the DoW, and Our Nation. Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield, demonstrating dedication to the medical care of fellow comrades in arms. Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast
Send us Fan MailFrom his office in Cologne late at night, Dr. Lukas Hensel walks us through what neurology in Germany really looks like on the ground, especially inside a university hospital where stroke, ICU-level decisions, and rare diagnoses show up disproportionately often.We follow his path into medicine and the “brain as a map” mindset that pulled him toward neurology, then zoom out to the structure of German neurology training. He explains a mentor-driven approach to specialization, the sharp divide between outpatient neurology and inpatient academic centers, and why protected research time can be both possible and precarious depending on staffing and grant funding. If you're curious about academic neurology careers, acute stroke care, and neurologic intensive care medicine, his day-to-day description is as practical as it is honest.The conversation also gets clinical: the dominant stroke risk profile in a Western aging population, the rising mix of vascular injury with neurodegenerative disease, and the steady presence of inflammatory conditions like multiple sclerosis. Dr. Hensel shares a standout interdisciplinary case where persistence, repeat biopsy, and tight coordination across services changed the trajectory for a patient with recurrent embolic events. We close with what he wants next for German healthcare and neurology: more effective rehabilitation, smarter use of digital markers, earlier prevention, and clearer end-of-life communication so treatment matches patient values.Subscribe for more global neurology conversations, share this with a colleague, and leave a review if it helped you think differently. What part of the German neurology system would you want to borrow or change first?Support the showHosts:Dr. Nupur Goel is a third-year neurology resident at Mass General Brigham in Boston, MA. Follow Dr. Nupur Goel on Twitter @mdgoelsDr. Blake Buletko is a vascular neurologist and program director of the Adult Neurology Residency Program at the Cleveland Clinic in Cleveland, OH. Follow Dr. Blake Buletko on Twitter @blakebuletkoFollow the Neurophilia Podcast on Twitter and Instagram @NeurophiliaPod
The American Hospital Association and West Health Institute have launched a three-year initiative to integrate and scale technology-enabled patient care solutions, supported by a $12 million investment. The program focuses on electronic health record optimization, virtual care, and artificial intelligence integration. Hospitals and health systems will access a digital hub for exploring solutions and engaging in peer-learning networks. The initiative builds on AHA's Patient Safety Initiative and expands on successful models with institutions like Mass General Brigham and Northwestern Medicine.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.
8:05PM: Excessive Napping May Be a Warning Sign of Underlying or Developing Health Conditions in Older Adults. What your napping habits could reveal… Guest: Dr. Chenlu Gao (pronounced CH-EN-LOU – G-AH-OW) – lead author of the study & an investigator in the Department of Anesthesiology in the Mass General Brigham, who is also an affiliated research fellow in the Division of Sleep and Circadian Disorders in the Department of Medicine 8:15PM: Project Bread's Walk for Hunger Returns to Boston Common Sunday, May 3rd. Now in its 58th year, the event draws participants for a family-friendly 3-mile loop as well as virtual walkers across the Commonwealth and country to raise $1 million annually to support Project Bread’s work connecting children and families across Massachusetts to reliable, nutritious food. Guest: Erin McAleer – CEO of Project Bread 8:30PM: The broader employment landscape in the veteran community. What types of options are available for our veterans when they finish their service? Guest: Chris Newsome - SVP Government Services & US Army Veteran with RecruitMilitary 8:45PM: Somerville rolls out tools and tips to tackle rodent activity head on! This week is “DeRATification” Week for taking on Somerville Rats! Guest: Somerville Mayor Jake WilsonSee omnystudio.com/listener for privacy information.
In today's episode, Haylie Pomroy sits down with Dr. David Systrom, a pulmonary and critical care physician at Mass General Brigham and Assistant Professor at Harvard Medical School, to explore the science behind exercise intolerance in ME/CFS and long COVID. Dr. Systrom breaks down the invasive cardiopulmonary exercise test (CPET) and what it reveals about blood flow, oxygen extraction, and mitochondrial dysfunction in patients who have been told their tests are normal. He explains why dysautonomia, small fiber neuropathy, and acquired mitochondrial dysfunction may be driving the fatigue, post-exertional malaise, and wide-ranging symptoms these patients experience every day. He also shares details on two active clinical trials at Brigham and Women's Hospital, including the LYFT trial testing low-dose naltrexone, Pyridostigmine (Mestinon), and the combination of both, as well as a muscle biopsy study designed to understand the role of the mitochondrion in post-exertional malaise. If you or someone you love has been dismissed, misdiagnosed, or left without answers, tune in to Fast Metabolism Matters Dr. David Systrom is a physician at Brigham and Women's Hospital. He is also an assistant professor of medicine at Harvard Medical School. He received his medical degree from Dartmouth Medical School. He then completed a residency in internal medicine at Emory University Hospital, followed by a fellowship in internal medicine at Massachusetts General Hospital. He is board-certified in internal medicine and pulmonary disease. An active investigator and director of the Massachusetts General Hospital Cardiopulmonary laboratory, Dr. Systrom regularly publishes research examining pulmonary hypertension, pulmonary vascular disease, right heart failure, and thromboembolic disease. He has authored over 130 peer-reviewed publications, has received funding from the National Institutes of Health and the American Heart Association, and has been named to the annual list of the Best Doctors in America. Dr. Systrom is a member of the American Thoracic Society, the American Heart Association and the American Physiological Society. He has special expertise in the pathophysiology of exercise intolerance in ME/CFS and Long Covid and is conducting clinical trials investigating the same Haylie Pomroy, Founder and CEO of The Haylie Pomroy Group, is a leading health strategist specializing in metabolism, weight loss, and integrative wellness. With over 25 years of experience, she has worked with top medical institutions and high-profile clients, developing targeted programs and supplements rooted in the "Food is Medicine" philosophy. Inspired by her own autoimmune journey, she combines expertise in nutrition, biochemistry, and patient advocacy to help others reclaim their health. She is a New York Times bestselling author of The Fast Metabolism Diet. Learn more about Haylie Pomroy's approach to wellness through her website: https://hayliepomroy.com Instagram: https://www.instagram.com/hayliepomroy Facebook: https://www.facebook.com/hayliepomroy YouTube: https://www.youtube.com/@hayliepomroy/videos LinkedIn: https://www.linkedin.com/in/hayliepomroy/ X: https://x.com/hayliepomroy
Prices at the supermarket, gas pump, and on your energy bill are only going up by the day, and a lot of people around New England are starting to feel the pinch. Food insecurity in Massachusetts is reaching levels we haven't seen in a long time, if ever. To get a better idea of just how much assistance is needed, the Greater Boston Food Bank teamed up with Mass General Brigham to put together a comprehensive report, complete with suggestions on what needs to be done to turn this trend around. Catherine D'Amato, President and CEO of the Greater Boston Food Bank, returns to the show to break down the report's findings with Nichole.See omnystudio.com/listener for privacy information.
In this bonus episode recorded live at the Collegis Education DisruptED summit in Phoenix, we spoke with Marc Austin and Reamer Bushardt to explore how partnerships between higher education institutions and employers can drive more relevant, workforce-aligned learning experiences. Through examples from healthcare and university initiatives, the conversation highlights how co-designed programs, continuous feedback loops, and shared goals can better prepare students for real-world careers. The discussion emphasizes that successful partnerships require trust, aligned values, and ongoing collaboration—not just transactional agreements. Ultimately, when done well, these partnerships create meaningful pathways for students, improve career outcomes, and strengthen the connection between education and the evolving needs of the workforce. Guest Names: Dr. Marc Austin, Vice Provost & Managing Director, Montclair Unbound Reamer Bushardt, Provost & VP for Academic Affairs, MGH Institute of Health Professions Guest Socials:Marc's LinkedIn Reamer's LinkedIn Guest Bios: Dr. Marc Austin serves as the Vice Provost and Managing Director for Montclair Unbound, Montclair State University's unit dedicated to extending the reach of the university through online and blended forms of education. Previously, he was the Associate Provost and Dean of Augusta University Online. Dr. Austin has spent the past two decades launching new, innovative approaches to online, executive and adult learning programs. Dr. Austin has also been a featured speaker for WCET, The Chronicle of Higher Education, ASU/GSV and others. He holds a PhD from Columbia University, a MSc from the London School of Economics and a BA from the University of Pennsylvania. Reamer L. Bushardt, PharmD, PA-C, DFAAPA serves as Professor, Provost and Vice President for Academic Affairs at the MGH Institute of Health Professions, which was founded by the Massachusetts General Hospital and is the only degree granting member of Mass General Brigham. As Provost, he is the Institute's chief academic officer with responsibility for all academic programs, research programs, faculty, and students. Dr. Bushardt is a seasoned educator, researcher, clinician, and administrator with experience in rural, community-based practice and faculty service within four academic health centers. He is licensed as a PA and pharmacist, specializing in the care of older adults and management of inappropriate polypharmacy and drug injury. As a PA, he has spent more than twenty-three years in primary care practice. - - - -Connect With Our Host:Dustin Ramsdellhttps://www.linkedin.com/in/dustinramsdell/About The Enrollify Podcast Network:The Higher Ed Geek is a part of the Enrollify Podcast Network. If you like this podcast, chances are you'll like other Enrollify shows too!Enrollify is made possible by Element451 — The AI Workforce Platform for Higher Ed. Learn more at element451.com. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The Strait of Hormuz is open as President Trump signals a deal with Iran is close. Public safety authorities say they're ready for Monday's Boston Marathon. There are warnings about a proposed collaboration between Mass General Brigham and CVS. Stay in "The Loop" with WBZ NewsRadio.See omnystudio.com/listener for privacy information.
Why does it feel like everyone's a fitness influencer these days?! Posting workout videos without science-based advice is one thing, but promoting supplements that aren't only mislabeled but sometimes not even legally on the market is another. And it's more common than you think. Host Maria Kestane speaks to Rohil Daliwal, an associate researcher at Mass General Brigham to discuss the highly-saturated and barely-regulated workout supplement market. We love feedback at The Big Story, as well as suggestions for future episodes. You can find us:Through email at hello@thebigstorypodcast.ca Or @thebigstory.bsky.social on Bluesky
It took over 30 years, but Kris Kinar, a Saskatoon-based construction worker living with EPP, is finally starting to get answers for his rare condition called erythropoietic protoporphyria, which causes intense pain from sun exposure. He met Dr. Amy Yeung, Physician at Massachusetts General Hospital, living with EPP, through a trial at Mass General Brigham, which is seeing great success. The pair join Evan to share their story and what's next in terms of treatment.
Editor's Choice: Same day discharge after minimally invasive interval debulking surgery in advanced stage ovarian cancerEditorial: Same-day discharge in advanced ovarian cancer as a milestone of surgical evolution and patient selectionHosted by: Gregg Nelson, MD, PhD, FRCSC University of Calgary, Calgary, Alberta CanadaFeaturing: Surabhi Tewari, MD, Department of Obstetrics and Gynecology, Mass General Brigham, Harvard Medical School, Boston, MA, USAAlexander Melamed, MD MPH, Department of Obstetrics and Gynecology, Mass General Brigham, Harvard Medical School, Boston, MA, USAJose Alejandro Rauh-Hain, MD MPH, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USACheck out more content on the journal's homepage at https://www.gynecologiconcology-online.net
Dr. Roy Perlis, editor-in-chief of JAMA AI and psychiatrist-researcher at Mass General Brigham, joins to explore the evolving intersection of artificial intelligence and healthcare. Drawing on his deep experience and expertise working in neural networks, genetics, and electronic health records, Roy outlines where AI is genuinely delivering — like ambient scribes and clinical decision support — while urging clinicians to stay skeptical, look for clinically meaningful outcomes, and resist the de-skilling that comes with over-reliance on automation. We also discuss mental health stigma among physicians, the promise and peril of AI chatbots in psychiatric care, and the looming psychiatry workforce crisis, leaving listeners with one essential question: will AI actually make things better? Wish to help the show? Leave ⭐⭐⭐⭐⭐ on Apple. Subscribe here and send it to a friend.
Send us Fan MailPreventing transplant loss doesn't just save organs—it could eliminate hospitalizations, reduce lifelong medications, and transform millions of lives.Dr. Janine Gaiha-Rohrbach, Ph.D. is a globally recognized leader in immunology and medical strategy, currently serving as Head of Global Medical Immunology at Biogen ( https://www.biogen.com/ ). With a PhD in Immunology and Virology from the University Hospital of Berne and extensive postdoctoral research at the Ragon Institute of Mass General Brigham, MIT, and Harvard, Dr. Gaiha-Rohrbach has dedicated her career to translating complex scientific advances into high-impact patient care.Throughout her career, Dr. Gaiha-Rohrbach has driven innovation across diverse therapeutic areas, including HIV, hepatitis, NASH, and specialized immunology, leading multiple new product launches and shaping global strategies to expand patient access.At Biogen, Dr. Gaiha-Rohrbach now focuses on advancing therapies in immunology with an emphasis on areas of high unmet need, including the evolving field of kidney transplantation.On today's episode, we'll explore the future of kidney transplant care, the limitations of current treatments for antibody-mediated rejection, and how emerging therapies targeting the immune system are poised to transform patient outcomes.#KidneyTransplant #TransplantInnovation #Biogen #Immunology #AntibodyMediatedRejection #AMR #CD38 #Felzartamab #OrganTransplant #HealthcareInnovation #Biotech #DrugDevelopment #PrecisionMedicine #Nephrology #ChronicKidneyDisease #MedicalBreakthrough #FutureOfMedicine #Immunotherapy #TransplantMedicine #LifeSavingScience #Podcast #HealthcarePodcast #BiotechPodcast #SciencePodcastSupport the show
Predicting Clinical Responses to Asthma Biologics
Send us Fan MailNeurology looks very different when one specialist may serve hundreds of thousands of people and patients travel hours across states just to be seen. We sit down with two renowned Indian neurologists, Dr. Singal and Dr. Lalkaka, to map what neurology care really feels like in India and what the rest of us can learn from it.We talk through the daily reality of neurology practice in India, from outpatient clinics filled with headache, epilepsy, Parkinson's disease, stroke follow up, and psychosomatic complaints to inpatient care that still includes emergencies and complex diagnostic puzzles. They explain how the country's disease patterns have evolved, with fewer classic infection dominated presentations than in prior decades and more non communicable neurological disease as life expectancy rises, alongside growing visibility of dementia and cognitive impairment.The conversation goes beyond medicine into culture and systems. We unpack how joint family networks can provide powerful support for stroke recovery and memory decline, while also shifting decision making away from patient autonomy. We explore stigma around epilepsy, the impact of Ayurveda and homeopathy alongside Western evidence based care, and why palliative care and quality of life discussions remain difficult in many settings. They also break down the healthcare landscape, including government hospitals, trust hospitals, and corporate centers, plus the hard truth of out of pocket costs when insurance coverage is limited.We end with a forward look at neurology training, genetics, precision medicine, and AI, anchored by a clear principle: use tests and technology as tools, not masters, and never let the clinical exam or compassion fade. If you care about global neurology, medical education, or building smarter systems of care, you'll take something practical from this conversation. Subscribe, share the episode with a colleague, and leave a review with the biggest lesson you're taking into your next patient encounter.Support the showHosts:Dr. Nupur Goel is a third-year neurology resident at Mass General Brigham in Boston, MA. Follow Dr. Nupur Goel on Twitter @mdgoelsDr. Blake Buletko is a vascular neurologist and program director of the Adult Neurology Residency Program at the Cleveland Clinic in Cleveland, OH. Follow Dr. Blake Buletko on Twitter @blakebuletkoFollow the Neurophilia Podcast on Twitter and Instagram @NeurophiliaPod
These days people are using AI chatbots for everything. These chatbots have a wealth of information at their metaphorical fingertips. But the accuracy of the information that they offer us is, well, questionable. But it makes sense why some people turn to AI for medical advice. They’re usually free, which gives them an upper hand when healthcare in the United States is so expensive. They’re also easy to access, so people can get their questions answered immediately, instead of waiting for an opening at their doctor’s office. And they’re trained to be empathic, which is especially appealing to patients who don’t feel valued in medical settings. In this "Ask a Doctor" segment, we explore the world of health advice and chatbots with two medical professionals. Guests: Angad Singh is a family medicine physician. He's also an Associate Chief Clinical Information Officer and Clinical Associate Professor at UW Medicine. Danielle Bitterman is an assistant Professor at Harvard Medical School and Clinical Lead for Data Science and AI at Mass General Brigham. Related links: A.I. Chatbots Are Changing How Patients Get Medical Advice - The New York Times How to Use ChatGPT for Health Advice | Right as Rain Health Advice From A.I. Chatbots Is Frequently Wrong, Study Shows - The New York Times Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.
Six years after the pandemic began, millions are still living with Long COVID. New research shows why recovery looks so different from person to person. Dr. Bruce Levy and Tanayott Thaweethai, Ph.D., of Mass General Brigham, speak with hosts Mark Masselli and Margaret Flinter about their National Institutes of Health-funded RECOVER study published in Nature […] The post Long COVID Latest: What are the Unique Patterns? appeared first on Healthy Communities Online.
This episode is powered by LightpathLED, a trusted provider of professional-grade red and blue light therapy panels. As Nurse Doza shares, he's used red light therapy every day for over six years — both in his clinic and at home — and now relies on LightpathLED's dual-wavelength panel for enhanced skin health, mood support, and cellular energy production. If you're ready to invest in a panel backed by a clinician's daily use, LightpathLED is the brand Nurse Doza recommends to his patients, family, and friends.
Send us a textForget the assumption that modern neurology only thrives where resources are abundant. We sit down with Dr. Daniel Ontaneda and Dr. Nelson Maldonado—two Ecuadorian neurologists driving change across Latin America—to explore how world-class care is built on clinical craft, cultural fluency, and relentless advocacy. From bedside localization when the MRI is down to expanding stroke thrombolysis from a handful of cases to hundreds, their stories reveal a system where expertise is abundant but access can lag—and how that gap is closing.We retrace Dan's journey from Quito to leading-edge MS research, and Nelson's decision to return home to build services few believed possible. Together they unpack what training looks like across the region, including long-format medical school, rural service, and residencies that demand deep exam skills. We compare public and private systems in Ecuador, break down why patients often want clear directives rather than options, and examine how cultural beliefs and language shape adherence. The conversation digs into MS treatment in low- and middle-resource settings, the rise of highly effective disease-modifying therapies, and the pragmatic use of cost-effective options like rituximab.The episode also exposes a hidden threat: substandard medications entering through price-first procurement, undermining both acute care and chronic neurologic disease. Yet the momentum is real—regional MS registries, imaging collaborations that move faster than heavily regulated systems, and conferences that bring neurocritical care and MS experts under one roof. Even subspecialists practice broadly, treating Parkinson's disease, epilepsy, headache, and ICU cases in the same week, sharpening an exam-first mindset that delivers results.If you care about global neurology, stroke systems of care, MS access, and the practical ethics of delivering evidence-based treatment under constraints, this conversation will challenge assumptions and spark ideas. Subscribe, share with a colleague, and leave a review telling us where neurology should invest next.Support the showHosts:Dr. Nupur Goel is a third-year neurology resident at Mass General Brigham in Boston, MA. Follow Dr. Nupur Goel on Twitter @mdgoels Dr. Blake Buletko is a vascular neurologist and program director of the Adult Neurology Residency Program at the Cleveland Clinic in Cleveland, OH. Follow Dr. Blake Buletko on Twitter @blakebuletko Follow the Neurophilia Podcast on Twitter and Instagram @NeurophiliaPod
In this episode, Jaansi and Dr. Francis Shen unpack neurolaw, the emerging field at the intersection of brain science, law, and public policy. Together, they explore how neuroscience can reshape ideas, what debates about free will mean for criminal justice, and how brain-based explanations can either challenge or reinforce stigma, especially for marginalized communities. Tune in to hear why rigorous science, transparency, and community engagement is essential to advance health equity with these tools!Dr. Francis X. Shen, JD, PhD is a Professor of Law and faculty member in the Graduate Program in Neuroscience at the University of Minnesota, and an Associate Professor in the Harvard Medical School Center for Bioethics and the MGH Department of Psychiatry. He directs the Shen Neurolaw Lab, co-directs the Neurotech Justice Accelerator at Mass General Brigham, and is the Founding Director of the Dana Foundation Career Network in Neuroscience & Society.Check out Dr. Shen's work:Shen Neurolaw Lab: www.fxshen.com/shenlab/Dr. Shen for Hennepin County Attorney: www.shenforsafety.org/Dana Foundation Career Network in Neuroscience & Society: neuroxcareers.org/Neurotech Justice Accelerator: neurotechjustice.org/
Sex Differences in Asthma: What Genomics Can Teach Us
Dr. Jamie Colbert, a hospitalist at Mass General Brigham and Chief Medical Officer of Commure, joins the podcast to discuss how ambient AI is reshaping clinician presence, wellbeing, and patient trust—and what healthcare leaders must do to ensure AI enhances the human experience.
More on Trump's threats to Greenland and beyond Guest: Alexander Salt from the Canadian Global Affairs Institute Should police have access to Traffic Camera footage? Guest: Teresa Scassa Canada Research Chair in Information Law and Policy, Full Professor, Common Law Section, Faculty of Law, University of Ottawa How to beat Blue Monday Guest: Dr. Alexandra Gold, a Licensed Clinical Psychologist at Mass General Brigham, a teaching affiliate for Harvard Medical School Is Canada planning to send soldiers to Greenland? Guest: Stephen M. Saideman Paterson Chair in International Affairs Director, The Canadian Defence and Security Network Should we have basic income in Canada? Guest: Evelyn Forget, Distinguished professor, Community Health Sciences, University of Manitoba Learn more about your ad choices. Visit megaphone.fm/adchoices
10,000 – that's the magic number of steps often recommended for a healthy lifestyle. With recent research looking into whether that number is an accurate benchmark for health, could the number of steps taken per day have an impact on brain health and, specifically, cognitive decline? That's precisely what a new study from Harvard Medical School and Mass General Brigham sought to examine, looking at how physical activity, specifically step count, impacted cognitive decline for those living with Alzheimer's disease. Dr. Bri Breidenbach and Sarah Lose join the podcast to break down the results of this new study, as well as share what current research says about the effect of other kinds of physical activity, such as different intensity exercises, on the brain and Alzheimer's progression. Guests: Bri Breidenbach, PhD, scientist, exercise physiologist, Okonkwo Lab, and Sarah Lose, MS, research program manager, exercise physiologist, Okonkwo Lab, UW School of Medicine and Public Health Show Notes Read the study, “Physical activity as a modifiable risk factor in preclinical Alzheimer's disease,” published by the journal Nature Medicine on their website. Learn more about Dr. Breidenbach and Sarah Lose's work on the Okonkwo Lab website. Read “Association of Daily Step Count and Intensity With Incident Dementia in 78 430 Adults Living in the UK,” mentioned by Dr. Breidenbach at 12:01, on JAMA Neurology's website. Listen to Sarah Lose's previous episode, “Building the Brain: Finding the Cognitive Benefits of Physical Activity,” on our website. Learn more about physical activity and the six pillars of brain health on our website. Complete the Dementia Matters Feedback Survey to let us know what our show is doing well and how we can improve in the New Year! This anonymous survey is estimated to take about 5 minutes to complete and is open to all. Connect with us Find transcripts and more at our website. Email Dementia Matters: dementiamatters@medicine.wisc.edu Follow us on Facebook and Twitter. Subscribe to the Wisconsin Alzheimer's Disease Research Center's e-newsletter. Enjoy Dementia Matters? Consider making a gift to the Dementia Matters fund through the UW Initiative to End Alzheimer's. All donations go toward outreach and production.
WBZ NewsRadio's Jay Willett has more.See omnystudio.com/listener for privacy information.
This episode, recorded live at the Becker's 13th Annual CEO + CFO Roundtable, features Amy Lee, MJ, MBA, MBHA, FACMPE, President and COO of Nantucket Cottage Hospital/Mass General Brigham. She discusses the unique challenges of delivering care on an island, from workforce housing to telehealth partnerships, and how innovation and community support sustain high-quality care in a remote setting.In collaboration with R1.
In this episode, Dr. Bruno Fernandes acts as host alongside special guest co-host Dr. Carlos Quezada-Ruiz to welcome Dr. Rishi Singh, the newly appointed Chair of Ophthalmology at Harvard Medical School and Mass Eye and Ear, and Chair of the Integrated Department of Ophthalmology at Mass General Brigham. Dr. Singh joins the podcast just 42 days into his new tenure to discuss the transition from the Cleveland Clinic to one of the world's most prestigious academic institutions. Key topics in this episode include: The "First 90 Days" Approach: Why listening is more important than prescribing solutions when taking on a new leadership role. The Circuitous Career Path: How taking on "unsexy" jobs like coding and documentation can build the essential skills needed for executive leadership. AI Realism: Dr. Singh shares his cautious optimism regarding Artificial Intelligence, discussing why it won't solve basic logistical issues instantly and the dangers of relying on the "black box" without human oversight. Retina & Drug Development: A look at the logistical burdens of Wet AMD treatment, the complexities of clinical trials, and the potential (and current limitations) of gene therapy as a "Holy Grail." Mentorship: Why being "uncomfortable" is the best way to grow as a young ophthalmologist. About the Guest: Dr. Rishi Singh is a vitreoretinal surgeon and physician-scientist with over 300 peer-reviewed publications. He formerly served as Vice President and Chief Medical Officer at Cleveland Clinic Martin Hospitals.
In this episode of Gents Talk, supported by Bulova and Mass General Brigham, Dr. David Martin joins Samir Mourani to talk about all things related to the heart. A cardiologist and specialist in cardiac arrhythmias at Mass General Brigham, Dr. Martin discusses how the holidays, particularly alcohol consumption, can lead to "holiday heart syndrome," a condition that causes an irregular heartbeat called atrial fibrillation. Emergency rooms see an uptick in people with this rapid irregular rhythm around the holidays.The discussion also covers:- The effects of alcohol on the heart, including how it can damage the heart muscle and potentially lead to heart failure over time.- The connection between the heart and social isolation, which is considered a risk factor for heart problems.- Ways to improve heart health, including aerobic exercise and incorporating movement into everyday life.- Why very heavy weightlifting and isometric exercise are less beneficial for the heart compared to aerobic activities like running or biking.- The importance of managing risk factors for heart attacks, such as high blood pressure, high cholesterol, and diabetes.- The fact that it is never too late to make sustainable lifestyle changes to improve heart health.
We love to hear from our listeners. Send us a message.In Episode 118, Host Erin Harris talks to Alexander Cryer, Ph.D., Instructor in Medicine at Mass General Brigham, about a proof of concept strategy that reprograms tumor cells with mRNA lipid nanoparticles to overactivate the cGAS-STING pathway, forcing cancer cells to produce and export large amounts of the innate immune agonist cGAMP to stimulate surrounding immune cells and drive anti-tumor immunity. Dr. Cryer explains the basic biology of cGAS-STING and how his team restored this pathway in tumor cells and leveraged intratumoral LNP delivery to overcome nucleic acid delivery and targeting challenges. He also discusses future directions, the need to move beyond intratumoral administration with more targeted systemic delivery, and the broader concept of turning the tumor's own abundant cell population and evolutionarily conserved innate immune pathways into therapeutic allies rather than obstacles.Subscribe to the podcast!Apple | Spotify | YouTube Visit my website: Cell & Gene Connect with me on LinkedIn
In this episode, Bernard R. Jones, Vice President, MGB Behavioral & Mental Health, Mass General Brigham; Vice President, MGB Department of Psychiatry, Massachusetts General Hospital, Brigham & Women's Hospital, McLean Hospital, Brigham & Women's Faulkner Hospital, discusses his dual leadership roles across Mass General Brigham and the system's work to integrate psychiatric services, expand innovative treatments, and improve both patient and provider experience.
Synopsis: This episode is proudly sponsored by Quartzy. In this far-reaching conversation, Rahul Chaturvedi speaks with John Lepore, CEO & President of ProFound Therapeutics and CEO-Partner at Flagship Pioneering, tracing a career shaped by a deep commitment to understanding the causal machinery of human disease. John shares how a Harvard-trained physician-scientist evolved into a biotech leader building one of the industry's most ambitious platform companies. Reflecting on 17 years at GSK — from academic cardiologist to running global research — John describes the moment he realized traditional target discovery had reached its limits. That insight propelled him into Flagship's venture-creation ecosystem and ultimately into leading ProFound Therapeutics, where the team is uncovering tens of thousands of previously unknown human proteins that could fundamentally reshape drug discovery and unlock true first-in-class opportunities. John also offers a candid look at today's biotech leadership realities: navigating capital-tight markets, fostering high-trust pharma partnerships, making disciplined early kill decisions, and using AI to extract causal insights from vast proteomic datasets. Together, he and Rahul explore why the expanded human proteome may be medicine's next great frontier — and what it takes, scientifically and psychologically, to lead a company bold enough to pursue it. Biography: John Lepore, M.D., is CEO and President of ProFound Therapeutics and CEO-Partner at Flagship Pioneering, where he is leading a new era of drug discovery by harnessing the expanded proteome to build a pipeline of first-in-class medicines. A physician-scientist and accomplished pharma executive, he joined ProFound following a 17-year career at GSK, where he was most recently SVP, Head of Research, leading a 2,500+ person global team and driving a renewed focus on immunology and human genetics across target discovery and validation, modality platforms, drug discovery, and clinical translation. He also chaired GSK's Research Review and Investment Board, guiding capital allocation and R&D strategy. Under his leadership, GSK advanced 15 Phase 1 programs with first- or best-in-class potential and executed $1B+ in strategic R&D deals. Before joining the biopharma industry, Dr. Lepore was a faculty cardiologist and research investigator at the University of Pennsylvania, where his lab investigated the transcription regulation of cardiovascular development. He currently serves on the boards of ProFound, KSQ Therapeutics, and the Innovation Growth Board of Mass General Brigham. Dr. Lepore received his B.S. in Biology from the University of Scranton and his M.D. from Harvard Medical School, after which he completed his residency and post-doctoral training at Massachusetts General Hospital and the Harvard School of Public Health.
Sleep shapes your mood, memory, immune system, and long-term health, yet most of us aren't getting enough. Harvard Medical School and Mass General Brigham sleep scientist Dr. Elizabeth Klerman shares the three easiest science-backed changes proven to improve your sleep tonight, plus the myths that make things worse. If you're struggling to fall asleep, waking at 3 a.m., or dragging through the day, this episode is for you.
In this episode, Steve Tringale, President of Mass General Brigham Health Plan, shares how the organization is expanding its product portfolio, entering the dual eligible market, and investing in integrated digital care management to better support members across all stages of life.
Allergen- and Damage-sensing Epithelial Cells in the Airways
Pharmacy and Therapeutics (P&T) committees historically operated at the individual hospital level but have evolved into enterprise-wide governance programs due to health system expansion, unprecedented clinical and financial complexity of care, and the emergence of high impact and novel therapeutics. To address this, the Vizient Center for Pharmacy Practice Excellence convened an expert panel that concluded health system enterprise P&T committees are uniquely positioned to balance clinical value with financial stewardship and minimize practice variation. They issued best practice considerations representing a dynamic framework designed to evolve alongside emerging therapies, evolving technologies, and the ongoing transformation of health systems. Joining us today are two members of the expert panel. We have Connor Hanrahan, AVP, enterprise pharmacy services, medication outcomes and stewardship with Intermountain Health and Prabashni Reddy, who at the time of the panel was the executive director of medication use and policy at Mass General Brigham. Guest speakers: Prabashni Reddy, RPh, PharmD, MMedSc (former) Executive Director of Medication Use and Policy Mass General Brigham Connor Hanrahan, PharmD, MHA, MS, BCPS, CPHQ AVP, Medication Policy, Outcomes, and Stewardship Intermountain Health, Enterprise Pharmacy Services Host: Kerry Schwarz, PharmD, MPH Senior Clinical Manager, Evidence-Based Medicine and Outcomes Center for Pharmacy Practice Excellence (CPPE) Show Notes: [01:02-03:38] The value Prabashni and Conor saw in joining the expert panel [03:39-05:33] What Prabashni and Conor learned from interactions during the expert panel [05:34-10:55] Intriguing actionable enterprise P&T program insights panelists brought to the table that listeners can use [10:56-14:01] Use of criteria and principles to create successful and broadly applicable best practices [14:56-16:00] How our listeners can put this panel's best practices into action VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed
This is episode, we'll look at a national effort to advance clinical research and patient care through artificial intelligence. AI depends on data that are large, diverse, and well-labeled -- in contrast, most clinical data are siloed, inconsistent, and biased toward certain populations. The CHoRUS Network, part of the NIH's Bridge2AI consortium, is standardizing and harmonizing data from many hospitals so they can actually be used for training machine-learning models. Dr. Eric Rosenthal is Contact PI for the CHoRUS Network, Associate Professor at Harvard Medical School, and an epileptologist, clinical neurophysiologist, and neurointensivist at Mass General Brigham. He was interviewed about CHoRUS by Dr. Masoom Desai, neurointensivist at the University of New Mexico and site PI for the CHoRUS Network. Series 7, Episode 1 Disclosures: Dr. Desai disclosed: PI- MAPS-ABI locally funded by CBRR, UNMHSC, Site PI for RAISE, RESET, SAFER-EEG, KeSETT, SHINKEI-TBI trials, Site PI for CHoRUS, Bridge2AI, Site co-PI for ICECAP and Post-ICECAP. Dr. Rosenthal disclosed: Committee service on Bridge to AI and the Curing Coma Campaign
A large real-world study of over 1.2 million adults with type 2 diabetes found that SGLT2 inhibitors and GLP-1 receptor agonists reduced major cardiovascular events compared with metformin, while sulfonylureas and insulin increased risk. A separate French population study showed no association between first-trimester mRNA COVID-19 vaccination and congenital malformations, supporting vaccine safety in pregnancy. Finally, researchers at Mass General Brigham reported that large language models can produce “sycophantic” but incorrect medical advice, emphasizing the need for clinician oversight when using AI in healthcare.
In this episode of Bright Spots in Healthcare, we explore how human-centered design can uncover breakthrough solutions already hiding in plain sight. Dr. Kristian Olson, Vice President of Design Impact at Mass General Brigham and leader of the Springboard Studio, shares how slowing down to understand problems leads to faster, more effective innovation. The conversation dives into: The four pillars of effective healthcare innovation: design research, prototyping, supported implementation, and impact measurement How "stupidest ideas" exercises and question storming unlock creative solutions in frontline staff meetings Real results from Salem Hospital's mobility speedometer (300% increase in patient movement, reduced length of stay) The COVID testing booth prototype that saved $1 million per year while reducing gown usage by 97% Developing low-cost neonatal resuscitation devices in Uganda and India that improved ventilation skills Why frontline staff must be co-creators, not just implementers, of healthcare solutions This discussion offers practical frameworks for health plans, hospitals, and healthcare leaders looking to harness their teams' ingenuity and drive measurable improvement. Guest Bio: https://www.massgeneral.org/doctors/17235/kris-olson Resources & References MGB Springboard Studio: www.mgbbspringboardstudio.org Augmented Infant Resuscitator: ebinnovations.net Positive Deviance approach to solving malnutrition in Vietnam (referenced as inspiration) Partner with Bright Spots Ventures: If you are interested in speaking with the Bright Spots Ventures team to brainstorm how we can help you grow your business via content and relationships, email hkrish@brightspotsventures.com About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the "bright spots" in healthcare—proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com.
In this episode, Dr. Gregg Furie and Dr. Wynne Armand share how Mass General Brigham is leading the way in sustainable healthcare through renewable energy investments, emissions reduction, clinician engagement, and education. They discuss the system's progress toward net zero, the connection between climate and health, and practical steps for hospitals beginning their sustainability journey.
Dr. Stephen Dorner, a leader for Mass General Brigham's home hospital program, discusses the impact of the government shutdown.
NBC10 Boston's Sue O'Connell guest hosts with Jim. NAACP's Michael Curry on how Trump is replacing "woke" with his own version of diversity, plus a mini-lesson on the history of white supremacy, in today's context. Boston Globe business columnist Shirley Leung on whether Mayor Wu has paid enough attention to the city center and the Connecticut Sun WNBA team potentially moving to Boston.Boston Medical Center's Dr. Katherine Gergen Barnett on the return of the presidential fitness test, CVS and Mass General Brigham expanding primary care in Mass., and what's needed to actually expand IVF access. Tufts food policy analyst Corby Kummer on the vodka-energy drink mix up, how food stamp cuts could hurt local grocers, and where to find the best ice cream in the state.
If you're tired of picking apart your appearance, hiding your body, or never feeling good enough, this episode is for you. Today, you'll learn the 4 simple steps you can take to build lasting confidence and finally feel good in your body. This powerful episode was inspired by a raw and emotional conversation Mel had with viral comedian Jake Shane. When Jake admitted he hates how he looks and struggles with self-worth, it opened the door to a bigger truth: millions of people feel the exact same way—but don't know what to do about it. So, Mel called in the experts. In this episode, you'll hear from Mel and Jake and learn tools from two renowned psychiatrists: -Dr. Judith Joseph, MD, double board-certified psychiatrist, professor at Columbia and NYU Medical Schools, and author of the bestselling book High Functioning. -Dr. Ashwini Nadkarni, MD, Harvard Medical School professor and psychiatrist at Mass General Brigham who specializes in anxiety, OCD, PTSD, and depression. Together, they break down the surprising psychology behind body shame and give you a practical, proven roadmap to feeling better, starting now. You'll learn how to: Break free from body shame, obsession, and constant comparisonRewire your brain for confidence and lasting self-acceptanceUse 4 science-backed steps to heal how you see yourselfUnderstand the hidden psychology behind body image and self-talkUnpack the shocking research on how screens and modern life are distorting your self-image (and how to fix it)This isn't just a conversation. It's your roadmap to healing, backed by science. After listening you will have the tools, the science, and the mindset shift you need to stop hiding—and start seeing yourself clearly. Because when you change how you see yourself, you change everything. For more resources, click here for the podcast episode page. If you liked this episode, you'll love listening to this one next: How to Build Real Confidence: 7 Truths to Unlock Your Authentic SelfConnect with Mel: Get Mel's #1 bestselling book, The Let Them TheoryWatch the episodes on YouTubeFollow Mel on Instagram The Mel Robbins Podcast InstagramMel's TikTok Sign up for Mel's personal letter Subscribe to SiriusXM Podcasts+ to listen to new episodes ad-freeDisclaimer